Initial Statement of Beneficial Ownership (3)
24 September 2015 - 12:39AM
Edgar (US Regulatory)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE
PRESENTS, that RPC PHARMA LIMITED, A Malta company, hereby constitute and appoint Beverly J. Schafman, Elliott M. Smith and Joel
Rubinstein, and each of them, my true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution
for me and in my name, place and stead, to sign any Form ID (Uniform Application for Access Codes to File on EDGAR), Schedule 13D
or 13G, reports on Form 3 (Initial Statement of Beneficial Ownership of Securities), Form 4 (Statement of Changes in Beneficial
Ownership of Securities) and Form 5 (Annual Statement of Beneficial Ownership of Securities) relating to transactions by me in
ordinary shares or other securities of Celsus Therapeutics plc and all amendments thereto, and to file the same, with the Securities
and Exchange Commission and the appropriate securities exchange, granting unto said attorneys-in-fact and agents, and each of them,
or their substitutes, full power and authority to do and perform each and every act and thing requisite or necessary to be done
in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their substitutes, may lawfully do or cause to be done by virtue
hereof. This Power of Attorney shall be effective until such time as I deliver a written revocation thereof to the above-named
attorneys-in-fact and agents.
Dated: |
September 16, 2015 |
|
/s/ Ray Prudo |
|
|
|
|
Director |
|
Akari Therapeutics Plc (NASDAQ:CLTX)
Historical Stock Chart
From May 2024 to Jun 2024
Akari Therapeutics Plc (NASDAQ:CLTX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Akari Therapeutics Plc News Articles